Investors

CNSX: MEND | OTC: MNNDF | FRA: 8TV

Subscribe for Investor News

woman out think
woman out think

Nurosene will revolutionize how consumers approach their performance and wellness needs.

Subscribe for Investor News

The Opportunity

1.5T Market

Health + Wellness

$10.5B by 2025

Performance

$14B by 2025

Self-Improvement

264M Affected Globally

Mental Health

The Nuro Solution

Nuro – The world’s first app that understands the underlying brain biology by using our proprietary Virtual Neural Scan.

Nuro – Will make recommendations that improve specific core neural networks and improve brain coherence.

Nurosene
– Will own the world’s most advanced brain based population data set.

Nurosene – Will drive this data through our advanced AI platform – NetraMark’s NetraAI.

NetraAI – Will identify precision drugs and nutraceuticals and we will hold a carried interest in these candidates.

Corporate Directory

Nurosene

[Head Office]

1655 Dupont St. #Suite 101

Toronto, ON M6P 3S9

investors@nurosene.com

Fasken Martineau DuMoulin LLP

[Legal]

2400 - 333 Bay St.

Toronto, ON M5H 2T6

416.366.8381

MNP LLP

[Auditors]

111 Richmond St. W Suite 300

Toronto, ON M5H 2G4

416.596.1711

Odyssey Trust

[Transfer Agent]

United Kingdom Building 323

409 Granville Street

Vancouver, BC V6C 1T2

1.833.392.7716